Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BKD | Common Stock | Award | $0 | +4.44K | +8.93% | $0.00 | 54.1K | Jul 1, 2021 | Direct | F1 |
transaction | BKD | Common Stock | Disposed to Issuer | $0 | -22.4K | -41.37% | $0.00 | 31.7K | Jul 1, 2021 | Direct | F2 |
transaction | BKD | Common Stock | Tax liability | -$47.7K | -5.83K | -18.38% | $8.17 | 25.9K | Jul 1, 2021 | Direct | F3 |
Anna Gene O'Neal is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Represents the vesting of performance-based restricted stock units previously granted to the reporting person effective upon the closing of the sale of 80% of the Company's equity in its Health Care Services segment. |
F2 | Represents the forfeiture of a portion of the time-based restricted stock units previously granted to the reporting person on February 22, 2021. |
F3 | Represents share withholding to satisfy tax withholding obligations due upon the vesting of restricted stock and restricted stock units previously granted to the reporting person. |